Curcumin and indole drug co-crystal with high safety and anticancer activity and preparation method thereof
An anti-cancer activity, indole co-crystal technology, applied in drug combinations, anti-tumor drugs, organic chemical methods, etc., can solve the problems of thermodynamic instability, prone to agglomeration, poor stability, etc. The effect of transformation and environmental pollution is small
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0049] Preparation of curcumin-indole drug co-crystal: Accurately weigh 100 mg of curcumin and 31.8 mg of indole in a molar ratio of 1:1 with an electronic balance, mix well with a vortex mixer, add 30 mL of acetone, and ultrasonically dissolve the drug completely And mix evenly, transfer to a round-bottomed flask, use a vacuum rotary evaporator at a water bath temperature of 40 °C, a rotation speed of 200 r / min, and rotary evaporation under vacuum conditions to completely remove the solvent, and then place it in a 40 °C vacuum drying oven to dry. Over night, the solvent was completely evaporated to obtain an orange-red solid powder product.
[0050] The curcumin and indole co-crystals obtained in Example 1 were characterized by powder X-ray diffraction (PXRD), and the instrument was Bruker D8 Advance from Germany, and the obtained PXRD pattern was as attached. figure 1 As shown in, wherein a is the PXRD pattern of the curcumin bulk drug, b is the PXRD pattern of the indole bu...
Embodiment 2
[0063] Preparation of curcumin-indole drug co-crystal: Accurately weigh 100 mg of curcumin and 63.6 mg of indole in a molar ratio of 1:2 with an electronic balance, mix well with a vortex mixer, add 30 mL of acetone, and ultrasonically dissolve the drug completely And mix evenly, transfer to a round-bottomed flask, use a vacuum rotary evaporator at a water bath temperature of 40 °C, a rotation speed of 200 r / min, and rotary evaporation under vacuum conditions to completely remove the solvent, and then place it in a 40 °C vacuum drying oven to dry. Over night, the solvent was completely evaporated to obtain an orange-red solid powder product.
[0064] figure 1 The PXRD spectrum shown, image 3 The DSC spectral characteristics shown and Figure 4 The characteristics of the infrared spectrum shown indicate that the solid product obtained in this example is a co-crystal of curcumin and indole.
[0065] The solubility test of Example 2 was carried out, and the result was similar...
Embodiment 3
[0070] Preparation of curcumin-indole drug co-crystal: Accurately weigh 100 mg of curcumin and 95.4 mg of indole in a molar ratio of 1:3 with an electronic balance, mix well with a vortex mixer, add 30 mL of acetone, and ultrasonically dissolve the drug completely And mix evenly, transfer to a round-bottomed flask, use a vacuum rotary evaporator at a water bath temperature of 40 °C, a rotation speed of 200 r / min, and rotary evaporation under vacuum conditions to completely remove the solvent, and then place it in a 40 °C vacuum drying oven to dry. Overnight, the solvent was completely volatilized to obtain a solid powder product, namely the co-crystal of curcumin and indole drug.
[0071] figure 1 The PXRD spectrum shown, image 3 The DSC spectrum shown, Figure 4 The infrared spectrum characteristics shown all illustrate that the solid product obtained in this example is a co-crystal of curcumin and indole drug.
[0072] The solubility test of Example 3 was carried out, an...
PUM
| Property | Measurement | Unit |
|---|---|---|
| melting point | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 


